Here, we spotlight the current need for new treatments for diabetic kidney disease, we briefly summarize the biological effects of HDACs and the various classes of pharmacological HDAC inhibitor that have been developed to date and we review the preclinical studies that have reported the effects of HDAC inhibitor treatment in experimental diabetic kidney disease. This evidence concerns the gene HDAC9 and diabetic kidney disease.